Study title: Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data. Jamali F, Barrington KJ, Finer NN, Coutts RT, Torok-Both GA. Dev Pharmacol Ther. 1988;11(5):253-7.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Doxapram | |||||
| ATC code: R07AB01 | |||||
| Document link: | |||||
| Document date: 2015-01-29 | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | Y | Y | - | - | |